作者：
Manh-Cuong,Vo [1]
;
Sung-Hoon,Jung [2]
;
Van-Tan,Nguyen [3]
;
Van-Dinh-Huan,Tran [2]
;
Nodirjon,Ruzimurodov [4]
;
Sang Ki,Kim [2]
;
Xuan-Hung,Nguyen [2]
;
Mihee,Kim [5]
;
Ga-Young,Song [2]
;
Seo-Yeon,Ahn [6]
;
Jae-Sook,Ahn [3]
;
Deok-Hwan,Yang [7]
;
Hyeoung-Joon,Kim [4]
;
Je-Jung,Lee [4]
作者单位：
Institute of Research and Development, Duy Tan University, Danang, Viet Nam.
[1]
Research Center for Cancer Immunotherapy, Chonnam National University Hwasun Hospital, Hwasun, Jeollanamdo, Republic of Korea.
[2]
Vaxcell-Bio Therapeutics, Hwasun, Jeollanamdo, Republic of Korea.
[3]
Department of Hematology-Oncology, Chonnam National University Hwasun Hospital and Chonnam National University Medical School, Hwasun, Jeollanamdo, Republic of Korea.
[4]
Institute of Immunology and Human Genomics of the Academy of Sciences of the Republic of Uzbekistan, Uzbekistan.
[5]
Department of Laboratory and Companion Animal Science, College of Industrial Science, Kongju National University, Yesan-eup, Yesan-gun, Chungnam, Republic of Korea.
[6]
Hi-Tech Center and Vinmec-VinUni Institute of Immunology, Vinmec Healthcare system, Hanoi, Vietnam.
[7]
DOI
10.1016/j.heliyon.2024.e27892
PMID
38524535
发布时间
2024-03-26
换一批
换一批
